US Stock MarketDetailed Quotes

CRVS Corvus Pharmaceuticals

Watchlist

2.080
+0.050+2.46%

Close May 10 16:00 ET

130.11MMarket Cap-4078P/E (TTM)

Corvus Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

36.42%-5.16M

11.43%-23.94M

31.54%-5.17M

21.58%-5.43M

14.70%-5.22M

-26.26%-8.11M

26.40%-27.02M

-10.08%-7.55M

17.76%-6.93M

51.59%-6.12M

Net income from continuing operations

27.59%-5.7M

34.57%-27.03M

32.22%-6.65M

59.54%-6M

22.24%-6.5M

5.11%-7.87M

4.47%-41.31M

-6.28%-9.82M

-38.96%-14.83M

28.84%-8.36M

Operating gains losses

-113.63%-236K

-47.07%5.28M

-69.58%1.4M

-68.32%865K

-19.55%1.28M

66.28%1.73M

106.64%9.98M

80.38%4.62M

59.74%2.73M

244.71%1.6M

Depreciation and amortization

-59.65%23K

-58.86%151K

-70.21%28K

-68.09%30K

-60.87%36K

-34.48%57K

-20.22%367K

1.08%94K

-12.96%94K

-24.59%92K

Change In working capital

109.72%219K

-354.53%-3.59M

86.42%-391K

-113.99%-630K

-95.71%-319K

-4,500.00%-2.25M

143.63%1.41M

-176.30%-2.88M

740.54%4.5M

94.02%-163K

-Change in receivables

--0

793.83%562K

82.35%-15K

91.54%-11K

--429K

18.66%159K

84.02%-81K

63.20%-85K

52.38%-130K

--0

-Change in prepaid assets

-28.81%84K

-101.38%-8K

-64.64%134K

-103.45%-22K

67.79%-238K

-61.18%118K

309.75%581K

-52.51%379K

26.14%637K

59.33%-739K

-Change in payables and accrued expense

107.41%185K

-558.88%-4.03M

85.70%-468K

-114.80%-596K

-178.66%-468K

-430.15%-2.5M

136.21%878K

-99.09%-3.27M

539.15%4.03M

137.33%595K

-Change in other current assets

7.58%284K

2.59%1.11M

-25.75%274K

32.19%308K

9.17%262K

10.92%264K

179.18%1.08M

35.16%369K

111.00%233K

-74.82%240K

-Change in other current liabilities

-12.08%-334K

-17.30%-1.23M

-17.47%-316K

-17.05%-309K

-17.37%-304K

-17.32%-298K

-178.23%-1.05M

-13.03%-269K

-112.57%-264K

2.63%-259K

Cash from discontinued investing activities

Operating cash flow

36.42%-5.16M

11.43%-23.94M

31.54%-5.17M

21.58%-5.43M

14.70%-5.22M

-26.26%-8.11M

26.40%-27.02M

-10.08%-7.55M

17.76%-6.93M

51.59%-6.12M

Investing cash flow

Cash flow from continuing investing activities

-100.15%-7K

166.77%15.54M

40.29%-2.32M

477.17%17.55M

-236.59%-4.29M

117.99%4.6M

-207.96%-23.28M

-94.20%-3.88M

-12.42%3.04M

-79.40%3.14M

Net PPE purchase and sale

--0

86.23%-34K

--0

---34K

-4,840.00%-247K

540.00%22K

---265K

---4K

Net investment purchase and sale

-100.15%-7K

167.63%15.58M

40.63%-2.32M

430.89%17.55M

-236.42%-4.29M

118.13%4.64M

-206.79%-23.03M

-95.79%-3.9M

-4.78%3.31M

-79.37%3.14M

Cash from discontinued investing activities

Investing cash flow

-100.15%-7K

166.77%15.54M

40.29%-2.32M

477.17%17.55M

-236.59%-4.29M

117.99%4.6M

-207.96%-23.28M

-94.20%-3.88M

-12.42%3.04M

-79.40%3.14M

Financing cash flow

Cash flow from continuing financing activities

7.86M

335K

7.52M

Net common stock issuance

----

--7.84M

--0

--327K

----

--0

----

Proceeds from stock option exercised by employees

--0

--12K

--0

--8K

--0

--4K

--0

Cash from discontinued financing activities

Financing cash flow

--0

--7.86M

--0

--335K

--7.52M

--4K

--0

Net cash flow

Beginning cash position

-4.10%12.62M

-79.26%13.16M

-18.23%20.11M

-73.11%7.66M

-69.31%9.65M

-79.26%13.16M

285.65%63.46M

-65.99%24.59M

-51.66%28.48M

-30.25%31.46M

Current changes in cash

-47.33%-5.16M

98.93%-539K

34.51%-7.49M

420.06%12.45M

33.09%-2M

89.05%-3.51M

-207.01%-50.3M

-29.33%-11.43M

-129.07%-3.89M

-121.60%-2.98M

End cash Position

-22.77%7.46M

-4.10%12.62M

-18.23%20.11M

-73.11%7.66M

-69.31%9.65M

-79.26%13.16M

-65.99%24.59M

-51.66%28.48M

Free cash flow

36.69%-5.16M

12.18%-23.97M

31.54%-5.17M

24.46%-5.43M

14.75%-5.22M

-26.79%-8.15M

25.68%-27.29M

-10.00%-7.55M

14.61%-7.19M

51.55%-6.13M

Currency Unit

USD

Accounting Standards

US-GAAP

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	36.42%-5.16M	11.43%-23.94M	31.54%-5.17M	21.58%-5.43M	14.70%-5.22M	-26.26%-8.11M	26.40%-27.02M	-10.08%-7.55M	17.76%-6.93M	51.59%-6.12M
Net income from continuing operations	27.59%-5.7M	34.57%-27.03M	32.22%-6.65M	59.54%-6M	22.24%-6.5M	5.11%-7.87M	4.47%-41.31M	-6.28%-9.82M	-38.96%-14.83M	28.84%-8.36M
Operating gains losses	-113.63%-236K	-47.07%5.28M	-69.58%1.4M	-68.32%865K	-19.55%1.28M	66.28%1.73M	106.64%9.98M	80.38%4.62M	59.74%2.73M	244.71%1.6M
Depreciation and amortization	-59.65%23K	-58.86%151K	-70.21%28K	-68.09%30K	-60.87%36K	-34.48%57K	-20.22%367K	1.08%94K	-12.96%94K	-24.59%92K
Change In working capital	109.72%219K	-354.53%-3.59M	86.42%-391K	-113.99%-630K	-95.71%-319K	-4,500.00%-2.25M	143.63%1.41M	-176.30%-2.88M	740.54%4.5M	94.02%-163K
-Change in receivables	--0	793.83%562K	82.35%-15K	91.54%-11K	--429K	18.66%159K	84.02%-81K	63.20%-85K	52.38%-130K	--0
-Change in prepaid assets	-28.81%84K	-101.38%-8K	-64.64%134K	-103.45%-22K	67.79%-238K	-61.18%118K	309.75%581K	-52.51%379K	26.14%637K	59.33%-739K
-Change in payables and accrued expense	107.41%185K	-558.88%-4.03M	85.70%-468K	-114.80%-596K	-178.66%-468K	-430.15%-2.5M	136.21%878K	-99.09%-3.27M	539.15%4.03M	137.33%595K
-Change in other current assets	7.58%284K	2.59%1.11M	-25.75%274K	32.19%308K	9.17%262K	10.92%264K	179.18%1.08M	35.16%369K	111.00%233K	-74.82%240K
-Change in other current liabilities	-12.08%-334K	-17.30%-1.23M	-17.47%-316K	-17.05%-309K	-17.37%-304K	-17.32%-298K	-178.23%-1.05M	-13.03%-269K	-112.57%-264K	2.63%-259K
Cash from discontinued investing activities
Operating cash flow	36.42%-5.16M	11.43%-23.94M	31.54%-5.17M	21.58%-5.43M	14.70%-5.22M	-26.26%-8.11M	26.40%-27.02M	-10.08%-7.55M	17.76%-6.93M	51.59%-6.12M
Investing cash flow
Cash flow from continuing investing activities	-100.15%-7K	166.77%15.54M	40.29%-2.32M	477.17%17.55M	-236.59%-4.29M	117.99%4.6M	-207.96%-23.28M	-94.20%-3.88M	-12.42%3.04M	-79.40%3.14M
Net PPE purchase and sale	--0	86.23%-34K	--0	--0	--0	---34K	-4,840.00%-247K	540.00%22K	---265K	---4K
Net investment purchase and sale	-100.15%-7K	167.63%15.58M	40.63%-2.32M	430.89%17.55M	-236.42%-4.29M	118.13%4.64M	-206.79%-23.03M	-95.79%-3.9M	-4.78%3.31M	-79.37%3.14M
Cash from discontinued investing activities
Investing cash flow	-100.15%-7K	166.77%15.54M	40.29%-2.32M	477.17%17.55M	-236.59%-4.29M	117.99%4.6M	-207.96%-23.28M	-94.20%-3.88M	-12.42%3.04M	-79.40%3.14M
Financing cash flow
Cash flow from continuing financing activities	0	7.86M	0	335K	7.52M	4K	0	0	0	0
Net common stock issuance	----	--7.84M	--0	--327K	----	----	--0	--0	--0	----
Proceeds from stock option exercised by employees	--0	--12K	--0	--8K	--0	--4K	--0	--0	--0	--0
Cash from discontinued financing activities
Financing cash flow	--0	--7.86M	--0	--335K	--7.52M	--4K	--0	--0	--0	--0
Net cash flow
Beginning cash position	-4.10%12.62M	-79.26%13.16M	-18.23%20.11M	-73.11%7.66M	-69.31%9.65M	-79.26%13.16M	285.65%63.46M	-65.99%24.59M	-51.66%28.48M	-30.25%31.46M
Current changes in cash	-47.33%-5.16M	98.93%-539K	34.51%-7.49M	420.06%12.45M	33.09%-2M	89.05%-3.51M	-207.01%-50.3M	-29.33%-11.43M	-129.07%-3.89M	-121.60%-2.98M
End cash Position	-22.77%7.46M	-4.10%12.62M	-4.10%12.62M	-18.23%20.11M	-73.11%7.66M	-69.31%9.65M	-79.26%13.16M	-79.26%13.16M	-65.99%24.59M	-51.66%28.48M
Free cash flow	36.69%-5.16M	12.18%-23.97M	31.54%-5.17M	24.46%-5.43M	14.75%-5.22M	-26.79%-8.15M	25.68%-27.29M	-10.00%-7.55M	14.61%-7.19M	51.55%-6.13M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall